Visit Your Local PBS Station PBS Home PBS Home Programs A-Z TV Schedules Watch Video Donate Shop PBS Search PBS










 
. .
4 pages: | 1 | 2 | 3 | 4 |

Herbal Investigation

Photo of patient "getting"a cold
To test remedies, researchers must first insert the virus right into a subject's nose  

Although Turner's own Echinacea studies "showed no significant effect" in treating or preventing the common cold, other researchers have shown that the plant does stimulate the body's immune system. Which research is correct? They might both be. There are three different species of Echinacea used medicinally. Effectiveness may vary depending on the type of plant, where it is grown, and how it is harvested. Without standardizing Echinacea products, there is no way to know what brand contains what.


"The burden of proof should be on the manufacturers, but it's not," says Turner. "The industry is held to an entirely different standard."

Bill Soller believes that over time, stricter standards will be incorporated, and welcomed, across the industry. "In the end," he says, "it's in each company's best interest to have a process that works."

Yet, even with a more consistent product, consumers may be taking this treatment in vain. As helpful as a boost to the immune system may seem, there is insufficient proof that this boost actually helps treat colds, says Turner. What's more, not everyone benefits from giving his or her immune system a swift jolt. People with illnesses like rheumatoid arthritis, lupus, and diabetes might not react well to such supplements.

Photo of echinacea flower
The purple coneflower (Echinacea purpurea) was valued by Plains Indians for its medicinal effects  

Some manufacturers are beginning to take steps to alert the public to potential problems. Members of the CHPA recently adopted a voluntary labeling program to urge pregnant or nursing women to "consult a health professional" before taking certain supplements. Manufacturers of St. John's Wort, which has been shown to react poorly with certain prescription drugs, have been asked to carry a similar directive. Such labels are not yet required by law, however, and CHPA has asked the FDA to adopt these measures by spring 2001. While Soller admits that the entire industry will benefit from greater regulation, he stresses that the benefits the public reaps from DSHEA still far outweigh any negatives.

"In everything we do in life there are so many variables. We can't predict anything with absolute certainty," says Soller. "What we can do is continue to move the needle in a positive direction."
- - - -- - - - - - - -
4 pages: | 1 | 2 | 3 | 4 |

Photo: Craig Mailloux, Elk Mountain Nursery

return to show page

 

A Ticklish QuestionLaughing MattersCold ComfortWhy are Peppers Hot?Grains of Inspiration Teaching guide Science hotline video trailer Resources Contact Search Homepage